Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Scheipner

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Anticancer Research|January 9, 2021
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal CarcinomaLukas Scheipner, Maria Anna Smolle, Dominik Barth, et al.
Urology|December 3, 2024
Intermediate- and Long-term Results After Adjustable Transobturator Male System ImplantationSamra Jasarevic, Doroteja Jankovic, Georg C Hutterer, et al.
Neurourology and Urodynamics|January 15, 2024
Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomyLukas Scheipner, Doroteja Jankovic, Samra Jasarevic, et al.
BJU International|February 8, 2026
Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomyKristijan Skok, Lukas Scheipner, Sebastian Mannweiler, et al.
BJUI Compass|April 13, 2026
Impact of delayed elective urological surgery: A prospective observational studyIva Simunovic, Hanna Zurl, Julia Altziebler, et al.
Surgical Oncology|May 4, 2023
Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomyStefano Tappero, Cristina Cano Garcia, Reha-Baris Incesu, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Minerva Urology and Nephrology|January 19, 2026
MRI prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRI-targeted biopsyHanna Zurl, Stefan Embacher, Helmut Schöllnast, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2024
The Effect of Adrenalectomy on Overall Survival in Metastatic Adrenocortical CarcinomaAnis Assad, Reha-Baris Incesu, Simone Morra, et al.
Urologic Oncology|April 23, 2024
Prognostic significance of lymph node count in surgically treated patients with T<sub>2-4</sub> stage nonmetastatic adrenocortical carcinomaAnis Assad, Francesco Barletta, Reha-Baris Incesu, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Anticancer Research|January 9, 2021
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal CarcinomaLukas Scheipner, Maria Anna Smolle, Dominik Barth, et al.
Urology|December 3, 2024
Intermediate- and Long-term Results After Adjustable Transobturator Male System ImplantationSamra Jasarevic, Doroteja Jankovic, Georg C Hutterer, et al.
Neurourology and Urodynamics|January 15, 2024
Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomyLukas Scheipner, Doroteja Jankovic, Samra Jasarevic, et al.
BJU International|February 8, 2026
Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomyKristijan Skok, Lukas Scheipner, Sebastian Mannweiler, et al.
BJUI Compass|April 13, 2026
Impact of delayed elective urological surgery: A prospective observational studyIva Simunovic, Hanna Zurl, Julia Altziebler, et al.
Surgical Oncology|May 4, 2023
Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomyStefano Tappero, Cristina Cano Garcia, Reha-Baris Incesu, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Minerva Urology and Nephrology|January 19, 2026
MRI prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRI-targeted biopsyHanna Zurl, Stefan Embacher, Helmut Schöllnast, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2024
The Effect of Adrenalectomy on Overall Survival in Metastatic Adrenocortical CarcinomaAnis Assad, Reha-Baris Incesu, Simone Morra, et al.
Urologic Oncology|April 23, 2024
Prognostic significance of lymph node count in surgically treated patients with T<sub>2-4</sub> stage nonmetastatic adrenocortical carcinomaAnis Assad, Francesco Barletta, Reha-Baris Incesu, et al.
Pageof 7